Terence Wong

Advanced Prostate Cancer Treatment Extends Lives

DCI is among the first in the nation to offer a targeted radiopharmaceutical therapy for men with advanced prostate cancer that's progressed on other treatments.

March 20, 2023

DCI Research Disease Group

Terence Wong and patient receiving Pluvicto

Nuclear Medicine at Duke Garners National Recognition

The Division of Nuclear Medicine and Radiotheranostics was named a Comprehensive Radiopharmaceutical Therapy Center of Excellence; one of only 14 in the U.S.

August 18, 2022

Announcements Awards